Report Detail

Pharma & Healthcare Global Influenza Diagnostics Market Insights, Forecast to 2025

  • RnM2492285
  • |
  • 02 April, 2019
  • |
  • Global
  • |
  • 112 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC’s seasonal influenza vaccination for prevention and control of seasonal influenza; and the demand created for influenza diagnosis in the flu season.

North America and Europe are the largest consumers in influenza diagnostics and is expected to retain the higher growth rate during the next years due to strong growth in influenza diagnostics industry. China has witnessed a major chunk in influenza diagnostics in the Asia Pacific region. Actually, that is why manufacturers have several plants, usually close to aimed demand market.
All manufactures in the world are committed to the improvement of products. These two years, some of Chinese manufactures can almost catch up with the world's leading technology too. Most technologies are developed by the manufacturers instead of importing from other companies.
Many international manufacturers expand their business through building factories or investments in targeted markets. Also, many major players have built up plants in other countries.
The global Influenza Diagnostics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Influenza Diagnostics market based on company, product type, end user and key regions.

This report studies the global market size of Influenza Diagnostics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Influenza Diagnostics in these regions.
This research report categorizes the global Influenza Diagnostics market by top players/brands, region, type and end user. This report also studies the global Influenza Diagnostics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
Enigma Diagnostics
Focus Diagnostics

Market size by Product
RIDT
RT-PCR
Cell Culture
Market size by End User
Hospitals
POCT
Others (Laboratory diagnosis, etc.)

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Influenza Diagnostics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Influenza Diagnostics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Influenza Diagnostics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Influenza Diagnostics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Influenza Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Influenza Diagnostics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Influenza Diagnostics Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Influenza Diagnostics Market Size Growth Rate by Product
      • 1.4.2 RIDT
      • 1.4.3 RT-PCR
      • 1.4.4 Cell Culture
    • 1.5 Market by End User
      • 1.5.1 Global Influenza Diagnostics Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 POCT
      • 1.5.4 Others (Laboratory diagnosis, etc.)
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Influenza Diagnostics Market Size
      • 2.1.1 Global Influenza Diagnostics Revenue 2014-2025
      • 2.1.2 Global Influenza Diagnostics Sales 2014-2025
    • 2.2 Influenza Diagnostics Growth Rate by Regions
      • 2.2.1 Global Influenza Diagnostics Sales by Regions
      • 2.2.2 Global Influenza Diagnostics Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Influenza Diagnostics Sales by Manufacturers
      • 3.1.1 Influenza Diagnostics Sales by Manufacturers
      • 3.1.2 Influenza Diagnostics Sales Market Share by Manufacturers
      • 3.1.3 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Influenza Diagnostics Revenue by Manufacturers
      • 3.2.1 Influenza Diagnostics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Influenza Diagnostics Revenue Share by Manufacturers (2014-2019)
    • 3.3 Influenza Diagnostics Price by Manufacturers
    • 3.4 Influenza Diagnostics Manufacturing Base Distribution, Product Types
      • 3.4.1 Influenza Diagnostics Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Influenza Diagnostics Product Type
      • 3.4.3 Date of International Manufacturers Enter into Influenza Diagnostics Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Influenza Diagnostics Sales by Product
    • 4.2 Global Influenza Diagnostics Revenue by Product
    • 4.3 Influenza Diagnostics Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Influenza Diagnostics Breakdown Data by End User

    6 North America

    • 6.1 North America Influenza Diagnostics by Countries
      • 6.1.1 North America Influenza Diagnostics Sales by Countries
      • 6.1.2 North America Influenza Diagnostics Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Influenza Diagnostics by Product
    • 6.3 North America Influenza Diagnostics by End User

    7 Europe

    • 7.1 Europe Influenza Diagnostics by Countries
      • 7.1.1 Europe Influenza Diagnostics Sales by Countries
      • 7.1.2 Europe Influenza Diagnostics Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Influenza Diagnostics by Product
    • 7.3 Europe Influenza Diagnostics by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Influenza Diagnostics by Countries
      • 8.1.1 Asia Pacific Influenza Diagnostics Sales by Countries
      • 8.1.2 Asia Pacific Influenza Diagnostics Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Influenza Diagnostics by Product
    • 8.3 Asia Pacific Influenza Diagnostics by End User

    9 Central & South America

    • 9.1 Central & South America Influenza Diagnostics by Countries
      • 9.1.1 Central & South America Influenza Diagnostics Sales by Countries
      • 9.1.2 Central & South America Influenza Diagnostics Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Influenza Diagnostics by Product
    • 9.3 Central & South America Influenza Diagnostics by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Influenza Diagnostics by Countries
      • 10.1.1 Middle East and Africa Influenza Diagnostics Sales by Countries
      • 10.1.2 Middle East and Africa Influenza Diagnostics Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Influenza Diagnostics by Product
    • 10.3 Middle East and Africa Influenza Diagnostics by End User

    11 Company Profiles

    • 11.1 BD
      • 11.1.1 BD Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 BD Influenza Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 BD Influenza Diagnostics Products Offered
      • 11.1.5 BD Recent Development
    • 11.2 Abbott (Include Alere)
      • 11.2.1 Abbott (Include Alere) Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Abbott (Include Alere) Influenza Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Abbott (Include Alere) Influenza Diagnostics Products Offered
      • 11.2.5 Abbott (Include Alere) Recent Development
    • 11.3 Roche
      • 11.3.1 Roche Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Roche Influenza Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Roche Influenza Diagnostics Products Offered
      • 11.3.5 Roche Recent Development
    • 11.4 SIEMENS
      • 11.4.1 SIEMENS Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 SIEMENS Influenza Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 SIEMENS Influenza Diagnostics Products Offered
      • 11.4.5 SIEMENS Recent Development
    • 11.5 Analytik Jena
      • 11.5.1 Analytik Jena Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Analytik Jena Influenza Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Analytik Jena Influenza Diagnostics Products Offered
      • 11.5.5 Analytik Jena Recent Development
    • 11.6 Quidel
      • 11.6.1 Quidel Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Quidel Influenza Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Quidel Influenza Diagnostics Products Offered
      • 11.6.5 Quidel Recent Development
    • 11.7 Thermo Fisher
      • 11.7.1 Thermo Fisher Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Thermo Fisher Influenza Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Thermo Fisher Influenza Diagnostics Products Offered
      • 11.7.5 Thermo Fisher Recent Development
    • 11.8 Meridian Bioscience
      • 11.8.1 Meridian Bioscience Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Meridian Bioscience Influenza Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Meridian Bioscience Influenza Diagnostics Products Offered
      • 11.8.5 Meridian Bioscience Recent Development
    • 11.9 BioMerieux
      • 11.9.1 BioMerieux Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 BioMerieux Influenza Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 BioMerieux Influenza Diagnostics Products Offered
      • 11.9.5 BioMerieux Recent Development
    • 11.10 Sekisui Diagnostics
      • 11.10.1 Sekisui Diagnostics Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Sekisui Diagnostics Influenza Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Sekisui Diagnostics Influenza Diagnostics Products Offered
      • 11.10.5 Sekisui Diagnostics Recent Development
    • 11.11 Response Biomedical
    • 11.12 SA Scientific
    • 11.13 Enigma Diagnostics
    • 11.14 Focus Diagnostics

    12 Future Forecast

    • 12.1 Influenza Diagnostics Market Forecast by Regions
      • 12.1.1 Global Influenza Diagnostics Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Influenza Diagnostics Revenue Forecast by Regions 2019-2025
    • 12.2 Influenza Diagnostics Market Forecast by Product
      • 12.2.1 Global Influenza Diagnostics Sales Forecast by Product 2019-2025
      • 12.2.2 Global Influenza Diagnostics Revenue Forecast by Product 2019-2025
    • 12.3 Influenza Diagnostics Market Forecast by End User
    • 12.4 North America Influenza Diagnostics Forecast
    • 12.5 Europe Influenza Diagnostics Forecast
    • 12.6 Asia Pacific Influenza Diagnostics Forecast
    • 12.7 Central & South America Influenza Diagnostics Forecast
    • 12.8 Middle East and Africa Influenza Diagnostics Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Influenza Diagnostics Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Influenza Diagnostics . Industry analysis & Market Report on Influenza Diagnostics is a syndicated market report, published as Global Influenza Diagnostics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Influenza Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,131.70
      4,697.55
      6,263.40
      3,646.50
      5,469.75
      7,293.00
      605,007.00
      907,510.50
      1,210,014.00
      325,065.00
      487,597.50
      650,130.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report